Oral bioavailability of sr9011. The tradeoff is that while SR9011 may absorb better, it has far less published research behind it. In theory, this means that a lower dose of SR9011 could produce effects similar to or greater than those of SR9009. So the compound has a pretty low oral availability and is fast acting, but I would call the orally not available claim a myth. The only difference would be that SR9001 is more potent and has better efficacy, all without the anabolic risk being involved. Nov 19, 2018 · The SR9009 and SR9011 that we supply has always undergone a micronization process in order to increase this bioavailability, but it is still not on par with when these compounds are administered via injectable or IV pathways. Bioavailability refers to the extent and rate at which a drug is absorbed and becomes available at the site of action. [1] Dec 5, 2025 · How Is SR9009 Different From SR9011? SR9011 is essentially a follow-up compound to SR9009 designed to improve bioavailability. . I experimented initially with timings and doses but settled on 10mg first thing in the morning then second 10mg about an hour before training. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the Oct 30, 2025 · Key Differences: SR9009 vs SR9011 The primary difference between these two compounds is their bioavailability. SR9011 sublingual with GW501516 before intense cardio. I'm gonna make a batch of what WesleyInman mentioned and give that a try next. Due to its inherent physicochemical properties, SR9011 exhibits poor oral bioavailability, a critical hurdle for its preclinical and potential therapeutic development. Studies have shown that SR9011 is potent enough to help users shred off 10-15 pounds of fat, often linked to helping the body’s recovery and overall regulatory processes. Apr 9, 2024 · SR9011 is basically the same as Stenabolic when it comes to how it works, side effects and benefits. Never tried oral SR9009, can't give you a comparison. Although no pharmaceutical preparations are available yet, illicit use of SR9009 and SR9011 for SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC 50) = 790 nM for Rev-Erbα and IC 50 = 560 nM for Rev-ErbAβ. This data comes from mouse studies using a dose of 1mg/kg. These non-hormonal compounds are being studied for their ability to modulate circadian rhythm, fat metabolism, endurance, and inflammation. Sr9009 only has like 2% bioavailability orally so it's pretty much just a complete waste of money unless you're shooting it up. Fantastic plateau buster, major cardio capacity increase. Apr 19, 2018 · SR-9011 is a REV-ERB agonist. You would need to SR9009 and SR9011 are attractive as performance-enhancing substances due to their REV-ERB agonist effects and thus circadian rhythm modulation activity. Take it orally, hold under my tongue for as long as possible. The key difference between these two compounds is the bioavailability. sometimes these two doses are as close as 2 hours apart. SR9011 has been found to have better bioavailability than SR9009, meaning it is more effectively absorbed and utilized in the body when taken orally. I wonder how SR9011 compares against these parameters as well. In the world of performance and metabolic research, few compounds have sparked as much scientific curiosity as Rev-Erb agonists —particularly SR9009 and SR9011. bio Total content: 30 ml (equivalent to 600 mg of SR9011) Includes a 1 ml external dropper for dosing Usual Dosage I'm currently using sr9011 20mg a day. SR9011 vs SR9009 (Stenabolic) The main difference between the two compounds is that SR9011 has higher oral and sublingual bioavailability than SR9009. [11] Oct 30, 2025 · SR9011 was specifically created to be absorbed more easily by the body than SR9009. Most of the interest and literature still centers around SR9009. Product Presentation Contains a 20 mg/ml solution of SR9011 from Science. Although this doesn't render the compound inert, for comparison one of the most popular nutraceuticals that operates on similar cellular pathways is SIRT1 activator Resveratrol, derived from red wine, with a bioavailability of ~1%. Bioavailability refers to the portion of a substance that enters the circulation when introduced into the body and becomes available for use or elimination. Oral bioavailability of SR9011 is low (approximately 15-20% in rodents), attributed to extensive first-pass metabolism in the liver, though it represents an improvement over first-generation REV-ERB agonists like GSK4112. Typical ostarine dosage for women is like 5-10mg a day. And dosing once a day is fine Apr 18, 2021 · Have only used SR9009 TD using salvo. Hi, indeed there is no public data on SR9011's oral or sublingual bioavailability. usr fjy qmxbw qnnbir ssugu ads wce kfjbsz mraem qtm